Bartolucci, Roberta
Dosne, Anne-Gaëlle
Csonka, Dénes
Pérez-Ruixo, Juan José
Magni, Paolo
Poggesi, Italo http://orcid.org/0000-0003-3079-6954
Article History
Accepted: 9 June 2021
First Online: 23 June 2021
Declarations
:
: RB, AGD, DC, JJPR, PM, and IP contributed to the design of the work, the acquisition of the data, the analysis or interpretation of the data, and the preparation of the manuscript. All authors have approved the submitted version and are accountable for it.
: Anne-Gaëlle Dosne, Dénes Csonka, Juan José Pérez-Ruixo, and Italo Poggesi were employees and shareholders of Janssen Pharmaceutical Companies at the time this analysis was conducted.
: The clinical studies were supported by research funding from Actelion (currently, a Janssen pharmaceutical company).
: The studies were conducted in accordance with principles for human experimentation as defined in the Declaration of Helsinki and were approved by the human investigational review board of the study center and by the competent authority of the country.
: Informed consent was obtained from each subject before enrollment in the studies, after being advised of the potential risks and benefits, as well as the investigational nature of the studies.
: Not applicable.
: Not applicable.
: The NONMEM script of the final model is available as ESM.